Interleukin-22 protects against non-typeable Haemophilus influenzae infection: alteration during chronic obstructive pulmonary disease

Autor: Sharan, R., Perez-Cruz, M., Kervoaze, G., Gosset, Pierre, Weynants, V., Godfroid, F., Hermand, P., Trottein, F., Pichavant, M., Gosset, P.

Publikováno v: In Mucosal Immunology January 2017 10(1):139-149

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Analysis of the antigen-specific IFN-γ producing T-cell subsets in cattle experimentally infected with Mycobacterium bovis

Autor: Walravens, K. ^*, Wellemans, V., Weynants, V., Boelaert, F., deBergeyck, V., Letesson, J.-J., Huygen, K., Godfroid, J.

Publikováno v: In Veterinary Immunology and Immunopathology 2002 84(1):29-41

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Immunogenicity and safety of three doses of a bivalent (B : 4 : P1.19,15 and B : 4 : P1.7-2,4) meningococcal outer membrane vesicle vaccine in healthy adolescents

Autor: Boutriau D, Poolman J, Borrow R, Findlow J, Domingo J, Puig-Barbera J, Baldo J, Planelles V, Jubert A, Colomer J, Gil A, Levie K, Kervyn A, Weynants V, Dominguez F, Barbera R, Sotolongo F

Publikováno v: CLINICAL AND VACCINE IMMUNOLOGY
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname

An experimental bivalent meningococcal outer membrane vesicle (OMV) vaccine (B:4:P1.19,15 and BA: P1.7-2,4) has been developed to provide wide vaccine coverage particularly of the circulating strains in Europe. A randomized, controlled phase II study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::389e815483eb8ec4128116fe9f11822e
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=9016